Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125 USD | -1.65% | -3.63% | +0.69% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 49.69B |
---|---|---|---|---|---|
Net income 2024 * | 715M | Net income 2025 * | 897M | EV / Sales 2024 * | 11.8 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 994M | EV / Sales 2025 * | 9.84 x |
P/E ratio 2024 * |
71.2
x | P/E ratio 2025 * |
57.9
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | -1.65% | ||
1 week | -3.63% | ||
Current month | -1.92% | ||
1 month | -8.22% | ||
3 months | +6.77% | ||
6 months | +27.05% | ||
Current year | +0.69% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 17 M€ | +6.46% | - | |
1.04% | 14 M€ | -4.28% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 125 | -1.65% | 2,596,547 |
24-05-10 | 127 | -0.85% | 1,689,980 |
24-05-09 | 128.1 | +0.57% | 1,464,257 |
24-05-08 | 127.4 | -2.06% | 1,336,571 |
24-05-07 | 130.1 | +0.35% | 1,425,267 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.69% | 49.69B | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+8.54% | 44.46B | |
+2.13% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+14.80% | 25.32B | |
-1.73% | 24.6B |
- Stock Market
- Equities
- DXCM Stock